• TRM (USD/COP)COP 3,461.92 +1.37% +COP 46.82Colombia's official exchange rate (Financial Superintendence), valid Nov 21 to Nov 23
  • EuroCOP 3,804.64 +1.37% +COP 51.45Reference: TRM crossed with the European Central Bank rate of Nov 20; not the market quote
  • Mexican pesoCOP 181.56 +1.37% +COP 2.45Reference: TRM crossed with the European Central Bank rate of Nov 20; not the market quote

Atrys grows nearly 10% driven by Latin America and its oncology division

FinanceInternationalExpansiónAI summary
Image: Expansión

Atrys Health raised its revenue 9.7% in the first nine months of the year to 117 million euros, driven by its Latin American business and its oncology division. Revenue in Latin America grew 28% to 42 million, after more than doubling sales in Mexico. Ebitda rose 18% to 14 million and the company confirmed its guidance. Net financial debt stood at 37.5 million euros as of September 30, down 78%.

In 30 seconds

  • Revenue of 117 million euros through September, up 9.7%
  • Latin America billed 42 million (+28%) and Mexico more than doubled its revenue
  • Ebitda rose 18% to 14 million euros
Read the full story at Expansión

IASummary generated by artificial intelligence from a story by Expansión. It may contain errors: the original source prevails.

Comments

Be respectful. Comments reported by several people are hidden until a moderator reviews them.

You do not need an account to read, only to comment. Sign in with a code sent to your email or with your Google account. We only show the name you choose, never your email.

    Keep reading